Evidence Needed to Support the Clinical Utility of Molecular Diagnostics

Many decisions for cancer patient management depend on information derived from clinical laboratory tests in addition to that derived from the clinical evaluation of these patients. At this workshop, participants will discuss and debate the definition of clinical utility for oncologic treatment, the evidence needed to demonstrate clinical utility for a molecular diagnostic, how that evidence should be obtained, and how NCI can best assist in the demonstration of clinical utility in the context of clinical trials. NCI will use this workshop to inform decisions about its role in this endeavor. The workshop format will be primarily interactive, with most of the time devoted to small focused breakout discussion groups.

  • When: Thursday, January 10th, 2013, 8:00 AM - Friday, January 11th, 2013, 12:00 PM
  • Where: Bethesda, Building 45 Natcher, Main Auditorium
  • Event Type: Conference
  • Add to your calendar

Speakers

  • Steven Gutman
    Affiliation: [N/A].
  • Daniel Hayes
    Affiliation: [N/A].
  • Walter Koch
    Affiliation: Roche.
  • James Rae
    Affiliation: University of Michigan.
  • Steven Shak
    Affiliation: Genome Health.

Contacts

Click here to view the entire NCI at Frederick calendar. If you have any questions or would like to add your own event to the NCI at Frederick calendar, please contact the Conference Center at 301-846-5865 or ISPConferenceCenterStaff@mail.nih.gov.